HGS Lupus Drug, Submitted For FDA Approval
Filed in archive Drugs, Vaccines and Therapeutics , Other Biotechnology News on June 11, 2010
© cameronneylonOn Thursday, Human Genome Sciences filed for the marketing approval of BENLYSTA® (belimumab) to the US FDA as treatment for systemic lupus erythematosus (SLE).
When approved by the US FDA, Human Genome Sciences' BENLYSTA® (belimumab) would be the first new lupus drug in more than 50 years.
An investigational human monoclonal antibody drug, BENLYSTA® (belimumab) is the first in a new class of drugs called BLyS-specific inhibitors that recognize and inhibit the biological activity of B-lymphocyte stimulator (BLyS). In lupus, rheumatoid arthritis and other autoimmune diseases, elevated levels of BLyS are believed to contribute to the production of autoantibodies. Autoantibodies are antibodies that attack and destroy the body's own healthy tissues as very much the case in lupus.
On the other hand, HGS' partner - GlaxoSmithKline PLC - filed for the drug's approval in Europe on Friday.
© cameronneylon
Permalink: HGS Lupus Drug, Submitted For FDA Approval
Tags: BENLYSTA® (belimumab), lupus, lupus drug, Human Genome Sciences, GSK, systemic lupus erythematosus
Vote for HGS Lupus Drug, Submitted For FDA Approval:
|
Rating: 8.67 out of 3 vote(s) cast.
|
Response from:
Ds
(06/13/10 6:38pm)
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells
There is another Bio-Tech Co that is working on First of Kind Cancer treatment. PVCT. Check it out.